Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT06914778

Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales

Led by Hywel Dda Health Board · Updated on 2025-04-10

120

Participants Needed

1

Research Sites

248 weeks

Total Duration

On this page

Sponsors

H

Hywel Dda Health Board

Lead Sponsor

U

University of Aberdeen

Collaborating Sponsor

AI-Summary

What this Trial Is About

Diabetes mellitus is a disorder of sugar and fat metabolism which results in damage to the small blood vessels in various organs, this includes the retina - the part of the eye that processes light into a nerve impulse. This leads to damage and blindness via various different mechanisms that are not fully understood. In this study the objective is to recruit people with diabetes and various stages of diabetic eye disease and measure a large number of different chemicals within the blood that might be associated with damage and dysfunction within the retina. Additionally, it will examine the different bacteria within the gut that might affect disease in the eye via chemicals circulating in the blood. This will require participants to have blood samples taken and to provide urine samples. The blood will be analysed with specialised instruments to identify specific molecules circulating within the blood. Participants will also need to allow researchers to look at their medical records, previous photographs and specialist scans of the back of the eye to grade their diabetic retinopathy. This will allow us to identify potential ways in which these could be targeted for future benefit for people with diabetes to hopefully prevent deterioration of their vision.

CONDITIONS

Official Title

Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of type 2 diabetes mellitus
  • Male or female aged 18 to 80 years inclusive
Not Eligible

You will not qualify if you...

  • Unable or unwilling to give consent for the study
  • Prior treatment with intravitreal therapies for diabetic macular edema
  • Known infectious diseases that may risk the study team (e.g., tuberculosis, HIV, hepatitis)
  • Age 17 years or younger, or 81 years or older
  • Known genetic conditions affecting lipid metabolism

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Prince Philip Hospital

Llanelli, Wales, United Kingdom, SA14 8QF

Actively Recruiting

Loading map...

Research Team

F

Francis WB Sanders, MB BChir PhD FRCOphth

CONTACT

E

Eirini Skiadaresi

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

6

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here